Alison Moore, Chief Technical Officer at Allogene Therapeutics, Inc. (ALLO), sold 35,264 shares at $42.00 ($1.5M) on 2020-10-12, disclosed to the SEC on 2020-10-13.
Open-market sale of $1.5M ALLO by Chief Technical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.00 | 24,233 | $1.0M | 68.7% |
| 2 | $42.00 | 11,031 | $463K | 31.3% |
| Total | $42.00 avg | 35,264 | $1.5M | 100% |
| Filing → |
| ALLO | SELL | 2022-03-17 | $133K | — | Filing → |
| ALLO | SELL | 2021-03-17 | $470K | — | Filing → |
| ALLO | SELL | 2020-10-09 | $1.8M | — | Filing → |